CIM Investment Management’s Integra LifeSciences IART Stock Holding History

CIM Investment Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4,062	Closed	-$262K	–	338
2018 Q2	$262K	Sell	4,062 -5,903	-59%	-$366K	0.09%	295
2018 Q1	$551K	Buy	9,965 +2,964	+42%	+$155K	0.19%	145
2017 Q4	$335K	Sell	7,001 -10	-0.1%	-$489	0.11%	236
2017 Q3	$354K	Sell	7,011 -7,015	-50%	-$360K	0.13%	223
2017 Q2	$765K	Sell	14,026 -428	-3%	-$20.4K	0.27%	84
2017 Q1	$609K	Buy	+14,454	New	+$618K	0.21%	121

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIM Investment Management's IART Position: Q3 2018 in Review

CIM Investment Management sold out of Integra LifeSciences (IART) in Q3 2018, closing a stake of 4,062 shares — an estimated $262K sold.

CIM Investment Management first reported a position in IART in Q1 2017 and held it in 6 quarters. The position peaked at $765K in Q2 2017. 249 funds tracked by Wall St. Rank hold IART as of Q3 2018.

CIM Investment Management reported no remaining Integra LifeSciences position as of Q3 2018 after selling out during the quarter.
CIM Investment Management sold 4,062 Integra LifeSciences shares in Q3 2018, an estimated $262K.
CIM Investment Management first reported a position in Integra LifeSciences in Q1 2017 and held it in 6 quarters.
CIM Investment Management's Integra LifeSciences position peaked at $765K in Q2 2017.
249 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2018.

Based on CIM Investment Management's 13F filing for Q3 2018, filed 9 Nov 2018.